Barclays’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-596
Closed -$1K 4050
2020
Q4
$1K Sell
596
-233,706
-100% -$392K ﹤0.01% 3515
2020
Q3
$737K Sell
234,302
-13,622
-5% -$42.8K ﹤0.01% 2104
2020
Q2
$720K Buy
247,924
+27,203
+12% +$79K ﹤0.01% 2119
2020
Q1
$623K Buy
220,721
+105,794
+92% +$299K ﹤0.01% 2011
2019
Q4
$372K Sell
114,927
-157,472
-58% -$510K ﹤0.01% 2857
2019
Q3
$588K Buy
272,399
+82,305
+43% +$178K ﹤0.01% 2542
2019
Q2
$598K Buy
190,094
+55,904
+42% +$176K ﹤0.01% 2621
2019
Q1
$500K Buy
134,190
+23,649
+21% +$88.1K ﹤0.01% 2618
2018
Q4
$321K Sell
110,541
-302,528
-73% -$879K ﹤0.01% 2509
2018
Q3
$1.09M Buy
413,069
+293,071
+244% +$770K ﹤0.01% 2206
2018
Q2
$280K Buy
119,998
+51,253
+75% +$120K ﹤0.01% 2573
2018
Q1
$202K Buy
68,745
+7,246
+12% +$21.3K ﹤0.01% 2835
2017
Q4
$168K Buy
61,499
+30,000
+95% +$82K ﹤0.01% 2748
2017
Q3
$107K Buy
31,499
+16,831
+115% +$57.2K ﹤0.01% 2680
2017
Q2
$36K Sell
14,668
-42,588
-74% -$105K ﹤0.01% 3113
2017
Q1
$131K Sell
57,256
-53,588
-48% -$123K ﹤0.01% 2720
2016
Q4
$235K Buy
110,844
+90,818
+454% +$193K ﹤0.01% 2224
2016
Q3
$66K Sell
20,026
-423
-2% -$1.39K ﹤0.01% 2616
2016
Q2
$64K Sell
20,449
-84,834
-81% -$266K ﹤0.01% 2508
2016
Q1
$316K Buy
105,283
+72,851
+225% +$219K ﹤0.01% 1906
2015
Q4
$98K Sell
32,432
-147,160
-82% -$445K ﹤0.01% 2310
2015
Q3
$899K Sell
179,592
-3,493
-2% -$17.5K ﹤0.01% 1468
2015
Q2
$1.1M Buy
183,085
+10,036
+6% +$60.2K ﹤0.01% 1449
2015
Q1
$1.21M Sell
173,049
-34,438
-17% -$241K ﹤0.01% 1512
2014
Q4
$1.45M Buy
207,487
+5,767
+3% +$40.4K ﹤0.01% 1450
2014
Q3
$1.41M Sell
201,720
-944
-0.5% -$6.6K ﹤0.01% 1524
2014
Q2
$1.82M Buy
202,664
+164,003
+424% +$1.48M ﹤0.01% 1403
2014
Q1
$309K Buy
38,661
+23,076
+148% +$184K ﹤0.01% 2178
2013
Q4
$126K Buy
15,585
+5,649
+57% +$45.7K ﹤0.01% 2908
2013
Q3
$70K Sell
9,936
-5,440
-35% -$38.3K ﹤0.01% 3095
2013
Q2
$119K Buy
+15,376
New +$119K ﹤0.01% 2953